Report overview
Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
This report aims to provide a comprehensive presentation of the global market for Gastric Motility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Drugs. This report contains market size and forecasts of Gastric Motility Drugs in global, including the following market information:
Global Gastric Motility Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Gastric Motility Drugs Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Gastric Motility Drugs companies in 2022 (%)
The global Gastric Motility Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastric Motility Drugs include Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin and Sigma-Tau Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastric Motility Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Motility Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Poly Pill
Global Gastric Motility Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, by Application, 2022 (%)
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
Global Gastric Motility Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Gastric Motility Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Motility Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastric Motility Drugs revenues share in global market, 2022 (%)
Key companies Gastric Motility Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastric Motility Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Motility Drugs, market overview.
Chapter 2: Global Gastric Motility Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Motility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Motility Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
